Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community
CANNANNEW REPORT

Presenting data evaluating LP352 engagement of central 5-HT2C receptors via effects on prolactin, and assessing binding activity and functional agonism of LP352 at the 5-HT2 receptors Hosting scientific exhibit highlighting the ongoing Phase 1b/2a PACIFIC Study, and LP352, a novel, highly selective 5-HT2C superagonist in development for rare seizure disorders LA JOLLA, Calif.–(BUSINESS WIRE)–$LBPH #Epilepsy—Longboard […]

Excerpt only …
READ MORE BELOW
Source : Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community

reposted by Cannabis News World